Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Chicago
Sanofi
Incyte Corporation
Pfizer
University of Washington
Autolus Limited
Ipsen
University of Miami
Gamida Cell ltd
Case Comprehensive Cancer Center
Janssen Research & Development, LLC
ADC Therapeutics S.A.
Oncternal Therapeutics, Inc
Genmab
Hackensack Meridian Health
Columbia University
National Institutes of Health Clinical Center (CC)
Xencor, Inc.
Amgen
Memorial Sloan Kettering Cancer Center
ADC Therapeutics S.A.
Stanford University
University of Nebraska
University of Nebraska
City of Hope Medical Center
Sierra Oncology LLC - a GSK company
Eastern Cooperative Oncology Group
Rutgers, The State University of New Jersey
Asana BioSciences
AIDS Malignancy Consortium
Hoffmann-La Roche
Calithera Biosciences, Inc
Rush University Medical Center
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Molecular Templates, Inc.
Molecular Templates, Inc.
GlaxoSmithKline
Brown University
Spectrum Pharmaceuticals, Inc
Spectrum Pharmaceuticals, Inc
Hoffmann-La Roche
ADC Therapeutics S.A.
Northwestern University
Fred Hutchinson Cancer Center
Weprom
Fred Hutchinson Cancer Center
Pfizer
Fred Hutchinson Cancer Center